Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19
Yi Jiang, Wanchao Yin, H. Eric Xu
Biochemical and Biophysical Research Communications (2020) Vol. 538, pp. 47-53
Open Access | Times Cited: 145

Showing 1-25 of 145 citing articles:

Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis
Florian Kabinger, Carina Stiller, Jana Schmitzová, et al.
Nature Structural & Molecular Biology (2021) Vol. 28, Iss. 9, pp. 740-746
Open Access | Times Cited: 613
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Goran Kokić, Hauke S. Hillen, Dimitry Tegunov, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 544
Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19
Canrong Wu, Wanchao Yin, Yi Jiang, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 12, pp. 3021-3033
Open Access | Times Cited: 103
Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 82
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
Sareh Kakavandi, Iman Zare, Maryam Vaezjalali, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 67
A Comprehensive Review of Andrographis paniculata (Burm. f.) Nees and Its Constituents as Potential Lead Compounds for COVID-19 Drug Discovery
Aekkhaluck Intharuksa, Warunya Arunotayanun, Wipawadee Yooin, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4479-4479
Open Access | Times Cited: 66
Fidelity of Ribonucleotide Incorporation by the SARS-CoV-2 Replication Complex
Xingyu Yin, Horia Popa, Anthony Stapon, et al.
Journal of Molecular Biology (2023) Vol. 435, Iss. 5, pp. 167973-167973
Open Access | Times Cited: 24
NMPylation and de-NMPylation of SARS-CoV-2 nsp9 by the NiRAN domain
Bing Wang, Dmitri Svetlov, Irina Artsimovitch
Nucleic Acids Research (2021) Vol. 49, Iss. 15, pp. 8822-8835
Open Access | Times Cited: 43
In silico investigation on the inhibitory effect of fungal secondary metabolites on RNA dependent RNA polymerase of SARS-CoV-II: A docking and molecular dynamic simulation study
Kosar Sadat Ebrahimi, Mohabbat Ansari, Mahdieh S. Hosseyni Moghaddam, et al.
Computers in Biology and Medicine (2021) Vol. 135, pp. 104613-104613
Open Access | Times Cited: 41
Synthesis and greener pastures biological study of bis-thiadiazoles as potential Covid-19 drug candidates
Musa A. Said, Sayed M. Riyadh, Nadia S. Al‐Kaff, et al.
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 9, pp. 104101-104101
Open Access | Times Cited: 29
Targeting SARS-CoV-2 Non-Structural Proteins
W.G. Tam, Ana C. Lorenzo‐Leal, Luis R. Hernández, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 13002-13002
Open Access | Times Cited: 20
Earth-friendly-assessed silver-nanoparticles spectrophotometric method for rapid and sensitive analysis of Molnupiravir, an FDA-approved candidate for COVID-19: application on pharmaceutical formulation and dissolution test
Ahmed Mohamed, Ebrahim Abolmagd, Israa M. Nour, et al.
BMC Chemistry (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 19
Small Molecule Drugs Targeting Viral Polymerases
Deborah Palazzotti, Martina Sguilla, Giuseppe Manfroni, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 661-661
Open Access | Times Cited: 8
Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp)
Shabana Bibi, Mohammad Mehedi Hasan, Yuanbing Wang, et al.
Current Medicinal Chemistry (2021) Vol. 29, Iss. 1, pp. 152-162
Closed Access | Times Cited: 40
Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis
Florian Kabinger, Carina Stiller, Jana Schmitzová, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 38
Natural Products for the Prevention and Control of the COVID-19 Pandemic: Sustainable Bioresources
Rajeev K. Singla, Xuefei He, Hitesh Chopra, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 34
The first three waves of the Covid-19 pandemic hint at a limited genetic repertoire for SARS-CoV-2
Trudy M. Wassenaar, Visanu Wanchai, Gregory S. Buzard, et al.
FEMS Microbiology Reviews (2022) Vol. 46, Iss. 3
Open Access | Times Cited: 28
An update on inhibitors targeting RNA-dependent RNA polymerase for COVID-19 treatment: Promises and challenges
Xiao‐Ying Xu, Yuheng Chen, Xinyu Lu, et al.
Biochemical Pharmacology (2022) Vol. 205, pp. 115279-115279
Open Access | Times Cited: 24
Exploring the pharmacological mechanisms of star anise against COVID‐19 using network pharmacology and molecular docking
Ning Li, Ya Gao, Lingfei Liu, et al.
Food Safety and Health (2024)
Open Access | Times Cited: 5
Viral RNA Replication Suppression of SARS-CoV-2: Atomistic Insights into Inhibition Mechanisms of RdRp Machinery by ddhCTP
Giada Ciardullo, Angela Parise, Mario Prejanò, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 5, pp. 1593-1604
Closed Access | Times Cited: 5
In silicoidentification of novel benzophenone–coumarin derivatives as SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) inhibitors
Shashank M. Patil, Reshma Mary Martiz, Ramith Ramu, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 23, pp. 13032-13048
Closed Access | Times Cited: 32
Existing Drugs Considered as Promising in COVID-19 Therapy
Edyta Janik, Marcin Niemcewicz, Marcin Podogrocki, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5434-5434
Open Access | Times Cited: 29
Computational Simulations Identified Marine-Derived Natural Bioactive Compounds as Replication Inhibitors of SARS-CoV-2
Vikas Kumar, Shraddha Parate, Sanghwa Yoon, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 29
Allosteric Activation of SARS-CoV-2 RNA-Dependent RNA Polymerase by Remdesivir Triphosphate and Other Phosphorylated Nucleotides
Bing Wang, Vladimir Svetlov, Yuri I. Wolf, et al.
mBio (2021) Vol. 12, Iss. 3
Open Access | Times Cited: 29
Antiviral activities of 4H-chromen-4-one scaffold-containing flavonoids against SARS–CoV–2 using computational and in vitro approaches
Vinit Raj, Jin-Hyung Lee, Jae‐Jin Shim, et al.
Journal of Molecular Liquids (2022) Vol. 353, pp. 118775-118775
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top